Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma (NAMS) Cash from Investing Activities (2023 - 2025)

NewAmsterdam Pharma (NAMS) has disclosed Cash from Investing Activities for 3 consecutive years, with -$21.1 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 66.0% to -$21.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$174.9 million through Dec 2025, down 178.32% year-over-year, with the annual reading at -$174.9 million for FY2025, 178.32% down from the prior year.
  • Cash from Investing Activities hit -$21.1 million in Q4 2025 for NewAmsterdam Pharma, down from $2.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $2.9 million in Q1 2025 to a low of -$159.1 million in Q2 2025.
  • Historically, Cash from Investing Activities has averaged -$19.8 million across 3 years, with a median of -$42000.0 in 2023.
  • Biggest five-year swings in Cash from Investing Activities: crashed 2072533.33% in 2024 and later surged 3441.33% in 2025.
  • Year by year, Cash from Investing Activities stood at -$3000.0 in 2023, then plummeted by 2072533.33% to -$62.2 million in 2024, then surged by 66.0% to -$21.1 million in 2025.
  • Business Quant data shows Cash from Investing Activities for NAMS at -$21.1 million in Q4 2025, $2.5 million in Q3 2025, and -$159.1 million in Q2 2025.